H.C. Wainwright Flag KRRO-121 as Independent Value Driver for Korro Bio, Inc. (KRRO)
TheFly reported on January 29 that H.C. Wainwright upgraded KRRO from Neutral to Buy with a $20 price target.
Korro Bio Inc. (KRRO)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Lynx1 Capital Management Weston Nichols | 677,915 | $5,430,099 | 1.1% | |
| 2. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 600,000 | $4,806,000 | 0.16% | |
| 3. | Siren L.L.C. Raymond Debbane | 347,718 | $2,785,221 | -17% | 0.08% |
| 4. | 279,000 | $2,234,790 | 0% | ||
| 5. | 72 Investment Holdings Steve Cohen | 276,831 | $2,217,416 | 4.38% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.60 | 520 | $5,512.00 | 1,538,296 | 2026-03-31 | Filing | |
| $11.11 | 207,100 | $2,300,881.00 | 1,297,893 | 2026-03-10 | Filing | |
| $11.11 | 207,100 | $2,300,881.00 | 1,297,893 | 2026-03-10 | Filing | |
| $11.11 | 207,100 | $2,300,881.00 | 1,297,893 | 2026-03-10 | Filing | |
| $11.11 | 207,100 | $2,300,881.00 | 1,297,893 | 2026-03-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $70.00 | 800 | $56,000.00 | 0 | 2024-11-11 | Filing | |
| $82.89 | 25 | $2,072.25 | 0 | 2024-10-17 | Filing | |
| $81.48 | 317 | $25,829.16 | 25 | 2024-10-17 | Filing | |
| $80.50 | 4,961 | $399,373.89 | 342 | 2024-10-17 | Filing | |
| $79.79 | 1,815 | $144,820.85 | 5,303 | 2024-10-17 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 737 | $8,343 | 0% | |
| 2. | 691 | $7,822 | 0% | |
| 3. | 54 | $683 | 0% |
News See All
20 Best Biotech Stocks Under $20 to Buy Now
The U.S. biotechnology market enters 2026 as the largest global biotech market, with an estimated size of $552.39 billion in 2023, and is projected to grow to $1.24 trillion by 2030.
5 Most Promising Small-Cap Stocks According to Analysts
In this piece, we will take a look at the five most promising small-cap stocks according to analysts.
Hedge Fund Resource Center